Arman Oruc > Goodwin > Silicon Valley, United States > Lawyer Profile
Goodwin Offices
601 Marshall Street
Redwood City, CA 94063
CALIFORNIA
United States
- Firm Profile
- Go to...
Arman Oruc
Position
Partner
Career
Arman Oruc is co-chair of the firm’s Antitrust and Competition practice. He specializes in antitrust related issues, including regulatory clearance and approval of mergers and acquisitions, government investigations, antitrust litigation, and antitrust risks associated with strategic business practices. Arman was most recently part of the founding team of a life sciences company, helping grow the start-up into a late-stage clinical platform company. Arman’s experience in both merger clearance and antitrust litigation, combined with his in-house experience, gives him a unique perspective in his practice.
Education
JD, University of California, Berkeley 1996 / MA, Cambridge University 1993 / BA, Skidmore College 1992
Lawyer Rankings
United States > Antitrust > Merger control
Offering a strong focus on regulated industries such as life sciences and tech, the team at Goodwin has a particularly strong focus on strategic merger clearances, successfully preempting Second Requests from the DOJ and FTC, and a successful record in contentious merger cases. The firm continues to be active on high-profile mandates, notably representing iRobot in its proposed $1.7 billion acquisition by Amazon. The practice is jointly led by Andrew Lacy and Arman Oruc. Lacy is an experienced transactional antitrust advisor, while Oruc, who splits his time between DC and Los Angeles, is a key name for merger clearance and antitrust litigation. John Goheen joined the team from Simpson Thacher & Bartlett LLP in January 2023, expanding the firm’s reach across the tech, healthcare, pharma, retail and financial services sectors. Attorneys are based in Washington DC unless otherwise stated.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Shareholder activism